Shield Therapeutics (STX) Presentation at MELLO London November 2018 episode artwork

EPISODE · Dec 19, 2018 · 19 MIN

Shield Therapeutics (STX) Presentation at MELLO London November 2018

from PIWORLD Investor Podcasts · host piworld

This video can be seen at: https://www.piworld.co.uk/2018/12/14/shield-therapeutics-stx-presentation-at-mello-london-november-2018/   Shield Therapeutics (STX) presentation at Mello London 2018 By Tim Watts, CFO Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialisation of late-stage, hospital-focused pharmaceuticals. The Company’s product, Feraccru, is an oral treatment for iron deficiency anaemia (IDA) in patients for whom intravenous iron or blood transfusions is needed. It also has a pipeline of over three prescription pharmaceutical assets, including PT20, PT30 and PT40. PT20, which is in Phase II clinical trials, is used as a treatment for hypophosphatemia. PT30, which indicates advanced intravenous (IV) iron formulation, is in pre-clinical stage. Its PT40, which indicates generic IV iron formulation, is in pre-clinical trials. Feraccru, which indicates IDA in chronic kidney disease (CKD) and inflammatory bowel disease (IBD), is in Phase III clinical trials. Its other indications for Feraccru are in Phase II clinical trials. Introduction – 00:17 Iron deficiency and Feraccru – 01:56 Norgine licence headlines – 11:28 USA – 14:00 Financial – 15:15 Management team – 15:47 Anticipated news flow – 17:00 Key messages and investment highlights – 18:12

This video can be seen at: https://www.piworld.co.uk/2018/12/14/shield-therapeutics-stx-presentation-at-mello-london-november-2018/   Shield Therapeutics (STX) presentation at Mello London 2018By Tim Watts, CFO Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialisation of late-stage, hospital-focused pharmaceuticals. The Company’s product, Feraccru, is an oral treatment for iron deficiency anaemia (IDA) in patients for whom intravenous iron or blood transfusions is needed. It also has a pipeline of over three prescription pharmaceutical assets, including PT20, PT30 and PT40. PT20, which is in Phase II clinical trials, is used as a treatment for hypophosphatemia. PT30, which indicates advanced intravenous (IV) iron formulation, is in pre-clinical stage. Its PT40, which indicates generic IV iron formulation, is in pre-clinical trials. Feraccru, which indicates IDA in chronic kidney disease (CKD) and inflammatory bowel disease (IBD), is in Phase III clinical trials. Its other indications for Feraccru are in Phase II clinical trials. Introduction – 00:17Iron deficiency and Feraccru – 01:56Norgine licence headlines – 11:28USA – 14:00Financial – 15:15Management team – 15:47Anticipated news flow – 17:00Key messages and investment highlights – 18:12

NOW PLAYING

Shield Therapeutics (STX) Presentation at MELLO London November 2018

0:00 19:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

French Your Way Jessica: Native French teacher founder of French Your Way Boost your French listening skills and test your comprehension with this one of a kind series of podcasts. Get the chance to listen to a real conversation between native speakers talking at normal speed AND customise your learning experience through carefully designed sets of questions (2 levels of difficulty) available for download at www.frenchvoicespodcast.com. All interviews also come with the transcript. French teacher Jessica interviews native speakers of French from around the world who share a bit of their life and passion. Where else would you meet in one same place a French yoga teacher based in Melbourne, a soap manufacturer from Provence, or a couple cycling around the world? The Lee Olsen Show Lee Olsen CJF I want to help you improve all areas of your life by 3 types of podcasts!👉Blood, Sweat & Blessings-Interviews of normal people that have achieved BIG things!👉Series!!! For Love of the Horse- Brad Jackman DVM & Lee Olsen CJF, how to help your horse!👉Business Tips- Proven Life Changing Business Strategies with Lee Olsen Rich Dad's Guide to Investing II Robert T. Kiyosaki II Full Audiobook II Robert T. Kiyosaki Investing means different things to different people… and there is a huge difference between passive investing and becoming an active, engaged investor. Rich Dad’s Guide to Investing, one of the three core titles in the Rich Dad Series, covers the basic rules of investing, how to reduce your investment risk, how to convert your earned income into passive income… plus Rich Dad’s 10 Investor Controls.The Rich Dad philosophy makes a key distinction between managing your money and growing it… and understanding key principles of investing is the first step toward creating and growing wealth. This book delivers guidance, not guarantees, to help anyone begin the process of becoming an active investor on the road to financial freedom. 🎙️Truth and Testimony the Broadcast Ray Gauthier & Adrian Scott This Podcast discusses and teaches the word of God. You will hear about world news and how it relates to bible prophecy. You will also hear interviews and testimonies from men and women of God who have devoted their lives to serving Yeshua (Jesus). Hosted by Ray Gauthier and Adrian Scott. These two long term broadcast colleagues have joined forces once again to provide you the highest quality in broadcast excellence, all for the glory of Yahweh: the God of all creation!You can see most of the podcasts uploaded here at our Youtube Channel.https://www.youtube.com/@truthandtestimonythebroadcast

Frequently Asked Questions

How long is this episode of PIWORLD Investor Podcasts?

This episode is 19 minutes long.

When was this PIWORLD Investor Podcasts episode published?

This episode was published on December 19, 2018.

What is this episode about?

This video can be seen at: https://www.piworld.co.uk/2018/12/14/shield-therapeutics-stx-presentation-at-mello-london-november-2018/   Shield Therapeutics (STX) presentation at Mello London 2018 By Tim Watts, CFO Shield Therapeutics PLC is a...

Can I download this PIWORLD Investor Podcasts episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!